By KATIE THOMAS from NYT Health http://ift.tt/2jPFAN5
via
IFTTTA top candidate to head the agency, Jim O’Neill, advocates “progressive” approval, in which drugs proved safe could be sold to consumers even if not yet proved effective. February 5, 2017 at 12:00AM
No comments:
Post a Comment